Efficacy of Lanreotide versus Follow-Up in Early-Stage Duodeno-Pancreatic Neuroendocrine Tumors (NETs) Related to Multiple Endocrine Neoplasia Type 1 (MEN1): Preliminary Data

被引:0
|
作者
Ramundo, V [1 ]
Marciello, F. [1 ]
Modica, R. [1 ]
Marotta, V [1 ]
Pizza, G. [1 ]
Camera, L. [1 ]
Napolitano, V [2 ]
De Luca, L. [3 ]
Colao, A. [1 ]
Faggiano, A. [1 ]
机构
[1] Univ Naples Federico II, Naples, Italy
[2] Univ Naples 2, Naples, Italy
[3] Pellegrini Hosp, Naples, Italy
关键词
multiple endocrine neoplasia type 1; lanreotide; duodeno-pancreatic nets;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
K8
引用
收藏
页码:125 / 125
页数:1
相关论文
共 47 条
  • [1] Efficacy of lanreotide in early-stage duodeno-pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 (MEN1): preliminary data
    Ramundo, V.
    Marciello, F.
    Marotta, V.
    Modica, R.
    Del Prete, M.
    Camera, L.
    Napolitano, V.
    De Luca, L.
    Colao, A.
    Faggiano, A.
    WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 : S161 - S161
  • [2] Survival and Prognosis in Patients with Duodeno-Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1 Syndrome
    Modica, R.
    Lo Calzo, F.
    De Cicco, F.
    Bottiglieri, F.
    Sciammarella, C.
    Colao, A.
    Faggiano, A.
    NEUROENDOCRINOLOGY, 2018, 106 : 108 - 108
  • [3] Duodeno Pancreatic Neuroendocrine Tumors (DPNET) in Multiple Endocrine Neoplasia Type 1 (MEN1): An Italian Restrospective, Observational, Multicenter Study
    Modica, R.
    Davi, M., V
    Brighi, N.
    Massironi, S.
    Pusceddu, S.
    Zatelli, M. C.
    Albertelli, M.
    Malandrino, P.
    De Luca, I
    Grimaldi, F.
    Colao, A.
    Faggiano, A.
    NEUROENDOCRINOLOGY, 2019, 108 : 82 - 82
  • [4] Impact of Long-Acting Octreotide in Patients with Early-Stage MEN1-Related Duodeno-Pancreatic Neuroendocrine Tumors
    Ramundo, V
    Del Prete, M.
    Marotta, V
    Marciello, F.
    Camera, L.
    Circelli, L.
    Colantuoni, V
    Di Sarno, A.
    Carratu, A. C.
    De Luca di Roseto, C.
    Colao, A.
    Faggiano, A.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 273 - 274
  • [5] Concepts for screening and diagnostic follow-up in multiple endocrine neoplasia type 1 (MEN1)
    Karges, W
    Schaaf, L
    Dralle, H
    Boehm, BO
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2000, 108 (05) : 334 - 340
  • [6] Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours
    Ramundo, V.
    Del Prete, M.
    Marotta, V.
    Marciello, F.
    Camera, L.
    Napolitano, V.
    De Luca, L.
    Circelli, L.
    Colantuoni, V.
    Di Sarno, A.
    Carratu, A. C.
    di Roseto, C. de Luca
    Colao, A.
    Faggiano, A.
    CLINICAL ENDOCRINOLOGY, 2014, 80 (06) : 850 - 855
  • [7] How to Follow Up and When to Operate Asymptomatic Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1?
    Tonelli, Francesco
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2014, 48 (05) : 387 - 389
  • [8] Multiple endocrine neoplasia type 1 with MEN1 variant of unknown significance, in a patient after the diagnosed of pancreatic neuroendocrine neoplasia
    Tanaka, Yuko
    Niitani, Takafumi
    Matsumoto, Takatsugu
    Abe, Akihito
    Ishida, Kazuyuki
    Aoki, Taku
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (03): : 263 - 267
  • [9] Approach of Multiple Endocrine Neoplasia Type 1 (MEN1) Syndrome-Related Skin Tumors
    Baicoianu-Nilescu, Livia-Cristiana
    Gheorghe, Ana-Maria
    Carsote, Mara
    Dumitrascu, Mihai Cristian
    Sandru, Florica
    DIAGNOSTICS, 2022, 12 (11)
  • [10] Type 1 multiple endocrine neoplasia (MEN1):: contribution of genetic analysis to the screening and follow-up of a large French kindred
    Waterlot, C
    Porchet, N
    Bauters, C
    Decouix, M
    Wémeau, JL
    Proye, C
    Degand, PM
    Aubert, JP
    Cortet, C
    Dewailly, D
    CLINICAL ENDOCRINOLOGY, 1999, 51 (01) : 101 - 107